Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 4;60(9):1440-1448.
doi: 10.1515/cclm-2022-0347. Print 2022 Aug 26.

Serum free light chain analysis: persisting limitations with new kids on the block

Lieve Van Hoovels  1   2 , Martine Vercammen  3   4 , Louis Nevejan  1   5 , Margot Cornette  6   7 , Pieter-Jan Briers  3   5 , Dries Deeren  8 , Jan Van Droogenbroeck  9 , Karel Fostier  10 , Dieter De Smet  6
Affiliations

Serum free light chain analysis: persisting limitations with new kids on the block

Lieve Van Hoovels et al. Clin Chem Lab Med. .

Abstract

Objectives: Serum free light chain (sFLC) measurements have inherent analytical limitations impacting sFLC clinical interpretation. We evaluated analytical and diagnostic performance of three polyclonal sFLC assays on four analytical platforms.

Methods: sFLC concentration was measured using Diazyme FLC assays (Diazyme) on cobas c501/c503 analyzer (Roche); Freelite assays (The Binding Site) on Optilite analyzer (The Binding Site) and cobas c501 analyzer and Sebia FLC ELISA assays (Sebia) on AP22 ELITE analyzer (DAS). Imprecision, linearity, method comparison vs. Freelite/Optilite, antigen excess detection and reference value verification were assessed. Diagnostic performance was compared on 120 serum samples and on follow-up samples of five patients with κ and λ monoclonal gammopathy.

Results: Method comparison showed excellent correlation with Freelite/Optilite method for all assays. A large proportional negative bias was shown for both Sebia κ and λ ELISA and a significant positive proportional bias for λ in the low (<10 mg/L) Freelite/cobas c501 method. Clinically relevant underestimation of κ sFLC levels due to antigen excess was shown for 7% of each Diazyme/cobas application and for 11 and 32.1% of λ sFLC assay of respectively Diazyme/cobas and Sebia/AP22. sFLC reference values revealed application specific. Cohen's κ values were (very) good for κ sFLC but only moderate to good for λ sFLC. In 4/10 follow-up patients, significant differences in clinical interpretation between sFLC assays were noticed.

Conclusions: Important analytical limitations remain for all sFLC applications. Differences in reference values and diagnostic performance hamper interchangeability of sFLC assays. Assay specific sFLC decision guidelines are warranted.

Keywords: analytical limitations; free light chains; monoclonal gammopathy; reference ranges.

PubMed Disclaimer

References

    1. Caers, J, Garderet, L, Kortüm, KM, O’Dwyer, ME, van de Donk, NWCJ, Binder, M, et al.. European myeloma network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when. Haematologica 2018;103:1772–84. https://doi.org/10.3324/haematol.2018.189159.
    1. Nice guideline Myeloma: diagnosis and management [NG35]. Published: 10/2/2016 (revised 25/10/2018). Available from: https://www.nice.org.uk/guidance/ng35 [Accessed 13 Mar 2022].
    1. Kumar, S, Paiva, B, Anderson, KC, Durie, B, Landgren, O, Moreau, P, et al.. International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 2016;17:e328–46. https://doi.org/10.1016/s1470-2045(16)30206-6.
    1. Rajkumar, SV. Updated diagnostic criteria and staging system for multiple myeloma. Am Soc Clin Oncol Educ Book 2016;35:e418–23. https://doi.org/10.1200/edbk_159009.
    1. Rajkumar, SV, Dimopoulos, MA, Palumbo, A, Blade, J, Merlini, G, Mateos, MV, et al.. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014;15:e538–48. https://doi.org/10.1016/s1470-2045(14)70442-5.

MeSH terms

Substances

LinkOut - more resources